{ }
TUI AG, a Germany-based global tourism group, operates through three main segments: Hotels & Resorts, Cruises, and TUI Musement, across Northern, Central, and Western regions. The Hotels & Resorts segment includes group-owned hotel brands, while the Cruises segment features TUI Cruises and Marella Cruises. TUI Musement provides local services at holiday destinations, with regional operations covering the UK, Ireland, Germany, Austria, Poland, Switzerland, Belgium, the Netherlands, and France.
UBS has upgraded Coloplast A/S to a neutral rating. The company specializes in disposable medical products, with net sales divided into hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and voice and respiratory care (7.9%). Geographically, sales are primarily from the United States (21%), the United Kingdom (14%), and other regions (52.8%).
UBS has upgraded Coloplast A/S to a neutral rating. The company specializes in disposable medical products, with net sales primarily from hygiene products (43.4%), ostomy care (36.8%), wound care (11.9%), and voice/respiratory care (7.9%). Geographically, sales are led by the U.S. (21%), the U.K. (14%), and France (10.8%).
UBS has upgraded Coloplast to a neutral rating while maintaining its price target at DKK 858, citing reduced risks following the recent sale of its skin care business, which led to a 1% cut in sales estimates. The company specializes in disposable medical products, with significant sales in the USA and UK.
UBS has upgraded Coloplast A/S to a neutral rating. The company specializes in disposable medical products, with net sales primarily from hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and voice and respiratory care (7.9%). Geographically, sales are led by the United States (21%), the United Kingdom (14%), and France (10.8%), with other regions accounting for 52.8%.
UBS has upgraded Coloplast to a neutral rating while maintaining a price target of DKK 858. The company specializes in disposable medical products, with net sales primarily from hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and voice and respiratory care (7.9%). Geographically, sales are distributed with 21% in the U.S., 14% in the U.K., and 10.8% in France, among others.
UBS has upgraded Coloplast to a neutral rating while maintaining a price target of DKK 858. Coloplast A/S focuses on disposable medical products, with sales divided into hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and vocal and respiratory care (7.9%). Geographically, the company generates 1.4% of sales in Denmark, 21% in the USA, 14% in the UK, 10.8% in France, and 52.8% from other regions.
Denmark's Nykredit has made a DKr24bn ($3.5bn) cash offer to acquire Spar Nord Bank, representing a 49% premium on its share price, with completion expected in the first half of 2025. In other news, AllianceBernstein plans to sue Switzerland over the $17bn writedown of Credit Suisse's AT1 bonds, joining a lawsuit that claims investor rights were violated during the UBS takeover. Additionally, DBS Group, Mitsubishi UFJ Financial Group, and Sumitomo Mitsui Financial Group are potential bidders for Indonesia's Panin Bank, which has seen a significant rise in its share value this year. Morgan Stanley will pay $15mn to settle SEC allegations regarding inadequate fraud prevention measures at its Smith Barney unit.
Denmark’s largest mortgage lender, Nykredit Realkredit A/S, has agreed to acquire Spar Nord Bank A/S for approximately 24.7 billion kroner ($3.5 billion). The deal, which values Spar Nord at 210 kroner per share, has received the recommendation of Spar Nord’s board.
Novo Nordisk A/S focuses on the design, manufacture, and marketing of pharmaceutical products, with 92.6% of sales from diabetes and obesity treatments and 7.4% from rare disease therapies. Geographically, 54.9% of sales come from the United States, followed by Europe-Middle East-Africa at 21.9%, China at 7.2%, and other regions at 16%.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.